Getein Biotech Inc (603387) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Getein Biotech Inc (603387) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.90 Million ≈ $14.76 Million USD) by net assets (CN¥2.80 Billion ≈ $409.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Getein Biotech Inc for the company's overall valuation and market capitalisation.

Getein Biotech Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Getein Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Getein Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Getein Biotech Inc ranked by their cash flow conversion efficiency. Explore 603387 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sino-High (China) Co. Ltd. SHE:301076	N/A
New Found Gold Corp V:NFG	-0.158x
Alligo AB Series B ST:ALLIGO-B	0.053x
Guizhou Guihang Automotive Components Co Ltd SHG:600523	-0.002x
Tourism Finance Corporation of India Limited NSE:TFCILTD	-0.037x
Zhang Xiaoquan Inc. SHE:301055	N/A
Covenant Logistics Group, Inc. NYSE:CVLG	-0.026x
Grupo Supervielle S.A. B BA:SUPV	0.176x

Annual Cash Flow Conversion Efficiency for Getein Biotech Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Getein Biotech Inc from 2012 to 2025. View 603387 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.86 Billion ≈ $418.42 Million	CN¥392.59 Million ≈ $57.45 Million	0.137x	-11.68%
2024-12-31	CN¥2.72 Billion ≈ $398.16 Million	CN¥423.00 Million ≈ $61.90 Million	0.155x	+27.89%
2023-12-31	CN¥2.74 Billion ≈ $401.13 Million	CN¥333.22 Million ≈ $48.76 Million	0.122x	-32.93%
2022-12-31	CN¥2.66 Billion ≈ $389.91 Million	CN¥482.96 Million ≈ $70.67 Million	0.181x	-4.67%
2021-12-31	CN¥2.27 Billion ≈ $332.76 Million	CN¥432.36 Million ≈ $63.27 Million	0.190x	+105.44%
2020-12-31	CN¥2.00 Billion ≈ $293.25 Million	CN¥185.47 Million ≈ $27.14 Million	0.093x	-31.05%
2019-12-31	CN¥1.68 Billion ≈ $246.08 Million	CN¥225.73 Million ≈ $33.03 Million	0.134x	-0.76%
2018-12-31	CN¥1.38 Billion ≈ $202.40 Million	CN¥187.10 Million ≈ $27.38 Million	0.135x	-19.10%
2017-12-31	CN¥1.15 Billion ≈ $167.95 Million	CN¥191.91 Million ≈ $28.08 Million	0.167x	-63.22%
2016-12-31	CN¥342.96 Million ≈ $50.19 Million	CN¥155.91 Million ≈ $22.82 Million	0.455x	+0.31%
2015-12-31	CN¥268.60 Million ≈ $39.30 Million	CN¥121.73 Million ≈ $17.81 Million	0.453x	-24.02%
2014-12-31	CN¥165.19 Million ≈ $24.17 Million	CN¥98.53 Million ≈ $14.42 Million	0.596x	-16.03%
2013-12-31	CN¥84.06 Million ≈ $12.30 Million	CN¥59.72 Million ≈ $8.74 Million	0.710x	+21.27%
2012-12-31	CN¥40.63 Million ≈ $5.95 Million	CN¥23.80 Million ≈ $3.48 Million	0.586x	--

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$699.08 Million

CN¥4.78 Billion CNY

Market Cap Rank

#10666 Global

#2910 in China

Share Price

CN¥9.42

Change (1 day)

-0.63%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49